These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30465506)

  • 1. Personalized Medicine and Medicinal Chemistry: Toward a Legal Framework in the European Union.
    Duardo-Sánchez A; De Miguel Beriain I
    Curr Top Med Chem; 2018; 18(25):2165-2173. PubMed ID: 30465506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Experimental and Computational Tools for Drug Discovery: Medicinal Chemistry, Personalized Medicine, Ethical & Legal Issues - Part-V.
    Arrasate S; Duardo-Sánchez A; De Miguel Beriain I; Casabona CR; González-Díaz H
    Curr Top Med Chem; 2018; 18(25):2141-2142. PubMed ID: 30698106
    [No Abstract]   [Full Text] [Related]  

  • 3. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European healthcare systems readiness to shift from 'one-size fits all' to personalized medicine.
    Schee Genannt Halfmann S; Evangelatos N; Schröder-Bäck P; Brand A
    Per Med; 2017 Jan; 14(1):63-74. PubMed ID: 29749826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legal and ethical concerns in personalized medicine: a European perspective.
    Regniault A; Kupecz A; Gavey M; Mignolet O; De Carlo P; Meyer P; Bailey S
    Per Med; 2009 Sep; 6(5):517-528. PubMed ID: 29783304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Genomic Information Management System for Maintaining Healthy Genomic States and Application of Genomic Big Data in Clinical Research.
    Gim JA
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legal challenges for the implementation of advanced clinical digital decision support systems in Europe.
    Mitchell C; Ploem C
    J Clin Transl Res; 2018 Dec; 3(Suppl 3):424-430. PubMed ID: 30873491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A proposal for reforming psychologists' training in France and in the European Union].
    Bouchard JP
    Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects.
    Shoaib M; Rameez MAM; Hussain SA; Madadin M; Menezes RG
    Sci Eng Ethics; 2017 Aug; 23(4):1207-1212. PubMed ID: 27896605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating China in the International Consortium for Personalised Medicine: a position paper on innovation and digitalization in Personalized Medicine.
    Beccia F; Di Marcantonio M; Causio FA; Schleicher L; Wang L; Cadeddu C; Ricciardi W; Boccia S
    BMC Public Health; 2024 Feb; 24(1):464. PubMed ID: 38355452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposals for model-based paediatric medicinal development within the current European Union regulatory framework.
    Manolis E; Pons G
    Br J Clin Pharmacol; 2009 Oct; 68(4):493-501. PubMed ID: 19843052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
    Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
    Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized medicine, genomics, and pharmacogenomics: a primer for nurses.
    Blix A
    Clin J Oncol Nurs; 2014 Aug; 18(4):437-41. PubMed ID: 25095297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical Issues Surrounding Personalized Medicine: A Literature Review.
    Salari P; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):209-217. PubMed ID: 28282721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current topics on software use in medicinal chemistry: intellectual property, taxes, and regulatory issues.
    Duardo-Sánchez A; Patlewicz G; López-Díaz A
    Curr Top Med Chem; 2008; 8(18):1666-75. PubMed ID: 19075773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
    Kroes BH
    J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ethical framing of personalized medicine.
    Joly Y; Saulnier KM; Osien G; Knoppers BM
    Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):404-8. PubMed ID: 25054830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical implications of epigenetics in the era of personalized medicine.
    Santaló J; Berdasco M
    Clin Epigenetics; 2022 Mar; 14(1):44. PubMed ID: 35337378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When is the processing of data from medical implants lawful? The legal grounds for processing health-related personal data from ICT implantable medical devices for treatment purposes under EU data protection law.
    Lindstad S; Ludvigsen KR
    Med Law Rev; 2023 Aug; 31(3):317-339. PubMed ID: 36282992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.